Skip to content

Clinical trials

Phase 1/2 Liver Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Status: Unknown status Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20072
20121
20132
20141
20153
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cure&Sure Biotech Co., LTD1
FeRx1
First Affiliated Hospital of Zhejiang University1
ImmVira Pharma Co. Ltd1
Leaf Vertical Inc.1
Northwest Biotherapeutics1
Peking University Cancer Hospital & Institute1
Rutgers, The State University of New Jersey1
Samsung Medical Center1
Second Military Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms13
Carcinoma, Hepatocellular4
Pancreatic Neoplasms4
Colorectal Neoplasms3
Colonic Neoplasms2
Melanoma2
Neoplasm Metastasis2
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Cholangiocarcinoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.